New FDA expansion of U.S. age indication extends EVO ICL use for patients 21 to 60 years old – making EVO ICL available to nearly 8 million additional refractive patients Lens-based vision correction with EVO ICL is now the leading procedure for U.S. patients with -8.0 diopters and above U.S. refractive market continues to shift … [Read more…]
Workers warn underfunding and unsafe staffing levels are putting children at risk TORONTO–(BUSINESS WIRE)–CUPE Local 2316, representing workers at the Children’s Aid Society of Toronto, are officially in a legal strike position as negotiations between the union and the employer have not led to an agreement and workers warn that a broader provincial funding crisis … [Read more…]
This collaboration brings medical and dental data together to better understand patient journeys and support more integrated care BOSTON–(BUSINESS WIRE)–CareQuest Institute for Oral Health®, a national nonprofit focused on creating a more accessible, equitable, and integrated oral health system, today announced a new partnership with Innovaccer, a leading health care AI company, to integrate medical … [Read more…]
SAN DIEGO–(BUSINESS WIRE)–Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies, today announced that the first participant has been dosed in a Phase 1 clinical study of JANX011, a CD19-targeted bispecific engineered using the company’s proprietary Adaptive Immune Response Modulator (ARM) platform. JANX011 is being developed for … [Read more…]
Nawal Ouzren Chief Executive Officer to step down for personal reasons Amit Munshi, Chairman of Sensorion to assume role of Interim CEO MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, today announced that Nawal Ouzren, … [Read more…]
Gross sales of TWYMEEG® in Japan continued to accelerate, increasing by 15.0% in the fourth quarter of 2025 (October–December) compared with the previous quarter, and by 40% compared with the fourth quarter of 2024. Poxel generated revenue of €5.0 million for the year ended 31 December 2025 corresponding to 10% royalties on TWYMEEG net sales … [Read more…]
Partnership improves access to great dermatologic care AUSTIN, Texas–(BUSINESS WIRE)–Epiphany Dermatology, a leading dermatology company committed to improving access to exceptional dermatologic care, announced today it has expanded its presence in Missouri through its partnership with Regional Dermatology, LLC. Founded in 2010 by Sarah Jensen, M.D., Regional Dermatology has a long-established reputation of providing high-quality … [Read more…]
LOS ANGELES–(BUSINESS WIRE)–#MRD–A new survey-based Genomics Tracker focused on the EU-5 (France, Germany, Italy, Spain, and the United Kingdom) by DeciBio Consulting LLC provides updated insight into how genomics technologies are being evaluated, adopted, and used across Europe’s solid tumor oncology markets. The study is based on responses from 100+ medical oncologists and offers a … [Read more…]
Genetic complexity of wheat has long thwarted efforts to hybridize wheat, to realize the benefits of improved yield and the combination of beneficial traits X-Terra® is Europe’s first commercially scalable hybrid wheat BASEL, Switzerland–(BUSINESS WIRE)–Wheat is the world’s most genetically complex staple crop, with the wheat genome nearly six times the size of the human … [Read more…]
– MAJESTY, the first global Phase III study in primary membranous nephropathy, met its primary endpoint of complete remission at two years – – Up to 30% of people with membranous nephropathy progress to kidney failure over 10 years despite current treatment approaches; achieving complete remission can help delay or prevent this – – Gazyva … [Read more…]
